Usted buscó: intolerable (Inglés - Maltés)

these developments are unacceptable and intolerable.
dawn l-iżviluppi huma inaċċettabbli u intollerabbli.

eventually these hyperinflation costs became intolerable.
eventwalment dawn l-ispejjeż ta’ liperinflazzjoni saru intollerabbli.

treatment should be discontinued if progressive disease or intolerable toxicity is observed.
il-kura għandha titwaqqaf jekk tiġi osservata progressjoni tal-marda jew tossiċità li mhix ittollerata.

if toxicity becomes intolerable, temporary dose interruption until recovery to grade 1.
jekk it-tossiċità ssir intollerabbli, interrompi temporanjament id-doża sakemm jirkupra għal  grad 1.

dose reductions are recommended for events that, if persistent, could become serious or intolerable.
tnaqqis fid-doża huwa rakkomandat f’każ li, jekk persistenti, jistgħu jkunu serji jew intollerabbli.

the dose may need to be reduced or treatment stopped temporarily if serious or intolerable side effects occur.
id-doża jista’ jkollha bżonn titnaqqas jew il-kura titwaqqaf b’mod temporanju jekk iseħħu effetti sekondarji serji jew intollerabbli.

2.10 unemployment is reaching intolerable levels in many eu countries, with huge social and economic costs.
24.10 f’ħafna pajjiżi tal-ue, il-qgħad qed jilħaq livelli li ma jistgħux jiġu ttollerati, bi spejjeż soċjali u ekonomiċi enormi.

should an intolerable skin reaction occur, the cream should be removed by washing the area with mild soap and water.
jekk ikun hemm reazzjoni intollerabbli fuq il-ġilda, il-krema għandha titneħħa billi tinħasel l-erja b’sapuna hafifa u ilma.

if adverse reactions are intolerable or persistent, the dose should be reduced or treatment with pecfent replaced by another analgesic.
jekk ir-reazzjonijiet avversi ikunu intollerabbli jew persistenti, id-doża għandha titnaqqas jew il-kura b’pecfent tinbidel b’analġesiku ieħor.

if intolerable symptoms occur following a decrease in the dose or upon discontinuation of treatment, then resuming the previously prescribed dose may be considered.
jekk ifeġġu sintomi intollerabbli wara tnaqqis fid- doża jew wara twaqqif tal-kura, jista’ jiġi kkunsidrat li terġa’ tinbeda d-doża preċedenti ordnata.

providing patients do not experience intolerable side-effects, the dosage should be titrated to achieve a maximal therapeutic effect.
13 li ma jkunux jistgħu jittolleraw, id- dożaġġ għandu jkun ittitrat biex iwettaq l- effett terapewtiku massimu.

management of severe and/or intolerable suspected adverse reactions may require dose reduction and/or temporary interruption of votubia therapy.
l-immaniġġar ta’ reazzjonijiet avversi ssuspettati gravi jew intollerabbli jista’ jkollu bżonn tnaqqis fid-doża u/jew interruzzjoni temporanja tat-terapija b’votubia.

for photosensitivity grade 2 (intolerable) or greater, dose modifications are recommended (see section 4.2).
għal fotosensittività ta’ grad 2 (intollerabbli) jew akbar, huwa rrakkomandat modifikazzjonijiet fid- doża (ara sezzjoni 4.2).

this is a vitally important issue because wind and solar programmes are massively expensive, massively inefficient and are the biggest single factor in the intolerable increase in energy costs for homes and businesses.
din hija kwistjoni kruċjali għax il-programmi tal-enerġija mir-riħ u mix-xemx għandhom prezz għoli immens, huma ineffiċjenti ħafna u huma l-uniku fattur kbir li qed jwasslu għaż-żieda intollerabbli fil-prezzijiet tal-enerġija għad-djar u n-negozji.

in a clinical study of patients with oic, a daily dose of 50 mg was associated with an increased incidence of intolerable gastrointestinal effects (primarily abdominal pain).
fi studju kliniku tal-pazjenti b’oic, doża ta’ kuljum ta’ 50 mg kienet assoċjata ma’ żieda fl-inċidenza tal-effetti gastrointestinali intollerabbli (prinċipalment uġigħ ta’ żaqq).

grade 2 (intolerable) or grade ≥3 acneiform rash: general dose modification recommendations in table 1 for cotellic should be followed.
raxx akniformi ta’ grad 2 (intollerabbli) jew ta’ grad ≥3: għandhom jiġu segwiti r- rakkomandazzjonijiet ġenerali ta’ modifikazzjoni fid-doża f’tabella 1 għal cotellic.

grade 2 (intolerable) or grade ≥3 photosensitivity: cotellic and vemurafenib should be interrupted until resolution to grade ≤1.
fotosensittività ta’ grad 2 (intollerabbli) jew ta’ grad ≥3: cotellic u vemurafenib għandhom jiġu interrotti sakemm ikun hemm titjib għal grad ≤1.

if a patient develops dermatologic reactions that are grade 3 (ctcae v 4.0) or higher, or that are considered intolerable, the following dose modification is recommended:
jekk pazjent jiżviluppa reazzjonijiet dermatoloġiċi li huma ta’ grad 3 (ctcae v 4.0) jew akbar, jew li huma kkunsidrati intollerabbli, hija rakkomandata il-modifikazzjoni li ġejja fid-doża:

grade 2 (intolerable) or grade ≥3 non-acneiform or maculopapular rash: cotellic dosing can be continued without modification if clinically indicated.
raxx mhux akniformi jew makulopapulari ta’ grad 2 (intollerabbli) jew ta’ grad ≥3: id-dożaġġ ta’ cotellic jista’ jitkompla mingħajr modifikazzjoni jekk indikat klinikament.